Approvals/TGA/GAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial

Approved

STANDARD

GAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8e8ebff52500c0f1
Product Name: GAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial
Artg Id: 210562
Artg Name: GAZYVA obinutuzumab (rch) 1000 mg/40 mL concentrate solution for infusion vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2014-05-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a4ca40355d613fa024b6bae53768a06a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8760a1b1961a72f9e6e7bffe02b95a3d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

8e8ebff52500c0f1

Type

Standard